List of Contents

Clinical Trials Market Size, Share, and Trends 2024 to 2034

The global clinical trials market size is calculated at USD 87.42 billion in 2025 and is forecasted to reach around USD 149.58 billion by 2034, accelerating at a CAGR of 6.10% from 2025 to 2034. The North America clinical trials market size surpassed USD 49.67 billion in 2024 and is expanding at a CAGR of 6.30% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : February 2025
  • Report Code : 1185
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Clinical Trials Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Clinical Trials Market

5.1. Covid-19: Clinical Trials Industry Impact

5.2. Clinical Trials Business Impact Assessment: Covid-19

5.2.1. Services Challenges/Disruption

5.2.2. Market Trends and Clinical Trials Opportunities in the COVID-19 Landscape for Major Markets

5.3. Strategic Measures against Covid-19

5.3.1. Government Support and Initiative to Combat Covid-19

5.3.2. Proposal for Clinical Trials Market Players to deal with Covid-19 Pandemic Scenario

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.1.1. Growing prevalence of chronic disorders

6.1.1.2. Increasing number of clinical trials in developing regions

6.1.2. Market Restraints

6.1.2.1. Rigorous guidelines

6.1.3. Market Opportunities

6.1.3.1. Increasing demand for advanced treatments such as personalized medicines

6.1.3.2. Technological advancements

Chapter 7. Global Clinical Trials Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.1.1. Clinical Trials Market Revenue by Market Players

7.1.1.2. Clinical Trials Market Revenue Market Share by Market Players

7.1.2. Key Organic/Inorganic Strategies Adopted by Players

7.1.2.1. Phase Portfolio Expansion, Geographic Expansion, Phase Innovation

7.1.2.2. Merger and Acquisition, Collaboration and Partnerships

7.1.3. Market Players Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of End-users

Chapter 8. Global Clinical Trials Market, By Phase

8.1. Clinical Trials Market, by Phase

8.1.1. Phase 1

8.1.1.1. Market Revenue and Forecast

8.1.2. Phase 2

8.1.2.1. Market Revenue and Forecast

8.1.3. Phase 3

8.1.3.1. Market Revenue and Forecast

8.1.4. Phase 4

8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Clinical Trials Market, By Study Design

9.1. Clinical Trials Market, by Study Design

9.1.1. Observational

9.1.1.1. Market Revenue and Forecast

9.1.2. Interventional

9.1.2.1. Market Revenue and Forecast

9.1.3. Expanded Access

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global Clinical Trials Market, By Indication

10.1. Clinical Trials Market, by Indication

10.1.1. Oncology

10.1.1.1. Market Revenue and Forecast

10.1.2. Autoimmune/Inflammation

10.1.2.1. Market Revenue and Forecast

10.1.3. Diabetes

10.1.3.1. Market Revenue and Forecast

10.1.4. Central Nervous System

10.1.4.1. Market Revenue and Forecast

10.1.5. Cardiovascular

10.1.5.1. Market Revenue and Forecast

10.1.6. Pain Management

10.1.7. Market Revenue and Forecast

10.1.8. Others

10.1.8.1. Market Revenue and Forecast

Chapter 11. Global Clinical Trials Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue Forecast by Phase

11.1.2. Market Revenue Forecast by Study Design

11.1.3. Market Revenue Forecast by Indication

11.1.4. U.S

11.1.4.1. Market Revenue Forecast

11.1.5. Canada

11.1.5.1. Market Revenue Forecast

11.2. Europe

11.2.1. Market Revenue Forecast by Phase

11.2.2. Market Revenue Forecast by Study Design

11.2.3. Market Revenue Forecast by Indication

11.2.4. UK

11.2.4.1. Market Revenue Forecast

11.2.5. Germany

11.2.5.1. Market Revenue Forecast

11.2.6. France

11.2.6.1. Market Revenue Forecast

11.2.7. Rest of EU

11.2.7.1. Market Revenue Forecast

11.3. Asia Pacific (APAC)

11.3.1. Market Revenue Forecast by Phase

11.3.2. Market Revenue Forecast by Study Design

11.3.3. Market Revenue Forecast by Indication

11.3.4. China

11.3.4.1. Market Revenue Forecast

11.3.5. India

11.3.5.1. Market Revenue Forecast

11.3.6. Japan

11.3.6.1. Market Revenue Forecast

11.3.7. Rest of APAC

11.3.7.1. Market Revenue Forecast

11.4. LATAM

11.4.1. Market Revenue Forecast by Phase

11.4.2. Market Revenue Forecast by Study Design

11.4.3. Market Revenue Forecast by Indication

11.4.4. Brazil

11.4.4.1. Market Revenue Forecast

11.4.5. Rest of LATAM

11.4.5.1. Market Revenue Forecast

11.5. Middle East and Africa (MEA)

11.5.1. Market Revenue Forecast by Phase

11.5.2. Market Revenue Forecast by Study Design

11.5.3. Market Revenue Forecast by Indication

11.5.4. GCC

11.5.4.1. Market Revenue Forecast

11.5.5. North Africa

11.5.5.1. Market Revenue Forecast

11.5.6. South Africa

11.5.6.1. Market Revenue Forecast

11.5.7. Rest of MEA

11.5.7.1. Market Revenue Forecast

Chapter 12. Company Profiles

12.1. Parexel

12.1.1. Company Overview, Business Information, Regional Presence

12.1.2. Phase Portfolio Analysis

12.1.2.1. Product Details, Specification, Indication

12.1.3. Revenue, Price, and Gross Margin

12.1.4. Recent Developments and Strategies

12.2. IQVIA

12.2.1. Company Overview, Business Information, Regional Presence

12.2.2. Phase Portfolio Analysis

12.2.2.1. Product Details, Specification, Indication

12.2.3. Revenue, Price, and Gross Margin

12.2.4. Recent Developments and Strategies

12.3. Charles River Laboratory

12.3.1. Company Overview, Business Information, Regional Presence

12.3.2. Phase Portfolio Analysis

12.3.2.1. Product Details, Specification, Indication

12.3.3. Revenue, Price, and Gross Margin

12.3.4. Recent Developments and Strategies

12.4. Omnicare

12.4.1. Company Overview, Business Information, Regional Presence

12.4.2. Phase Portfolio Analysis

12.4.2.1. Product Details, Specification, Indication

12.4.3. Revenue, Price, and Gross Margin

12.4.4. Recent Developments and Strategies

12.5. Kendle

12.5.1. Company Overview, Business Information, Regional Presence

12.5.2. Phase Portfolio Analysis

12.5.2.1. Product Details, Specification, Indication

12.5.3. Revenue, Price, and Gross Margin

12.5.4. Recent Developments and Strategies

12.6. Chiltern

12.6.1. Company Overview, Business Information, Regional Presence

12.6.2. Phase Portfolio Analysis

12.6.2.1. Product Details, Specification, Indication

12.6.3. Revenue, Price, and Gross Margin

12.6.4. Recent Developments and Strategies

12.7. Pharmaceutical Product Development, LLC

12.7.1. Company Overview, Business Information, Regional Presence

12.7.2. Phase Portfolio Analysis

12.7.2.1. Product Details, Specification, Indication

12.7.3. Revenue, Price, and Gross Margin

12.7.4. Recent Developments and Strategies

12.8. Company 8

12.8.1. Company Overview, Business Information, Regional Presence

12.8.2. Phase Portfolio Analysis

12.8.2.1. Product Details, Specification, Indication

12.8.3. Revenue, Price, and Gross Margin

12.8.4. Recent Developments and Strategies

12.9. Company 9

12.9.1. Company Overview, Business Information, Regional Presence

12.9.2. Phase Portfolio Analysis

12.9.2.1. Product Details, Specification, Indication

12.9.3. Revenue, Price, and Gross Margin

12.9.4. Recent Developments and Strategies

12.10. Company 10

12.10.1. Company Overview, Business Information, Regional Presence

12.10.2. Phase Portfolio Analysis

12.10.2.1. Product Details, Specification, Indication

12.10.3. Revenue, Price, and Gross Margin

12.10.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Precedence Research announced, the global clinical trials market size was valued at USD 83.75 billion in 2024 and is expected to reach USD 149.58 billion by 2034.

The global clinical trials market is growing at a impressive CAGR of 6.10% during the forecast period 2025 to 2034.

Factors such as growing prevalence of chronic disorders, increasing number of clinical trials in developing regions, growing number of biologics, increasing demand for advanced treatments such as personalized medicines, outbreak of viral diseases, increasing cases of cancer globally, growing geriatric population and growing research and development expenditure are propelling the clinical trials market expansion across the globe.

The major companies operating in the worldwide clinical trials market are Parexel, IQVIA, Charles River Laboratory, Omnicare, Kendle, Chiltern, and Pharmaceutical Product Development, LLC. among others.

Interventional Study is projected to dominate the study design segment of clinical trials market revenue.

Constant research on cancer treatment and increasing demand for precision medicine are the major reasons responsible for high market share of oncology.?

Asia-Pacific is anticipated to witness the rapid growth rate, on account of increasing investment by governments in research and growing awareness regarding precision medicine.

Clinical Trials are a type of clinical research that are performed in people and are intended at assessing a behavioral, surgical, or medical intervention. Clinical Trials act as the prime way employed by the scientists to investigate if a new therapy, a medical device or anovel drug is secure and efficient in individuals.

Proceed To Buy

USD 5900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Plan your call and get expert insights!

Schedule a Meeting Schedule a Meeting

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us